Acute resistance exercise (RE) is emerging as a promising strategy to improve executive function, yet the underlying mechanisms remain unclear. In this study, 121 participants (aged 18–50) were randomly assigned to either a moderate‐intensity RE or rest intervention using a between‐subjects design. We examined the effects of acute RE on behavioral and neuroelectric measures of executive function during a modified Flanker task and an N‐back task, and collected lactate and blood pressure to explore possible physiological mechanisms. Results showed that following acute RE, blood lactate ( d = 2.06) and systolic blood pressure ( d = 0.99) significantly increased. Improvements in executive function were similarly observed following acute RE, including faster processing speed during inhibitory control ( d = 0.37) and working memory ( d = 0.46), and decreased P3 latency during inhibitory control ( d = 0.41). Moreover, exploratory mediation analyses revealed that systolic blood pressure mediated the effect of RE on response time during both the Flanker (−10.73 ± 4.99, 95% CI = −21.50 to −1.52) and N‐back (−28.20 ± 12.38, 95% CI = −53.22 to −5.37) tasks. Overall, these findings provide evidence that acute RE enhances neuroelectric and behavioral markers of inhibitory control and working memory performance and highlight the potential for systolic pressure as a mechanism through which acute RE influences cognition.
This is the first evaluation of the effects of heat therapy (HT) in heart failure with preserved ejection fraction (HFpEF). HT elicited multiple central and peripheral adaptations that impacted positively exercise tolerance in a preclinical model of HFpEF. HT adaptations included improvements in cardiac function, body composition, and skeletal muscle oxygenation (mediated partially via enhanced nitric oxide bioavailability). These novel findings indicate that HT may hold important clinical significance for the treatment of HFpEF.
Attenuation of sympathetic vasoconstriction during exercise (functional sympatholysis) contributes to skeletal muscle oxygen delivery–utilization matching. However, the extent to which muscle contractions impact noradrenergic regulation of interstitial oxygen pressures (; the driving force for blood–myocyte oxygen flux) is unknown. We tested the hypotheses that (1) muscle contractions would attenuate the noradrenaline‐induced reduction in muscle compared to rest (thus indicating functional sympatholysis) in healthy rats, and (2) functional sympatholysis would be impaired in rats with heart failure with preserved ejection fraction (HFpEF) but ameliorated with heat therapy. Skeletal muscle was determined via phosphorescence quenching in anaesthetized healthy (Sprague–Dawley, n = 14) and HFpEF rats (obese ZSF1, n = 20) at rest and during contractions following noradrenaline superfusion (5 × 10 −4 M). HFpEF rats underwent 8 weeks of heat therapy (HEAT, n = 10) or control treatment (CON; n = 10). Functional sympatholysis was evaluated based on the noradrenaline‐induced changes in at rest and during contractions normalized to mean arterial pressure (Δ/MAP; %/mmHg). Consistent with our hypothesis, muscle contractions attenuated the noradrenaline‐evoked reductions in healthy rats (rest: −0.50 ± 0.23, contractions: −0.25 ± 0.16; P < 0.05). Compared to healthy rats, the noradrenergic response at rest was exacerbated in HFpEF‐CON (−0.85 ± 0.13; P < 0.05) but restored in HFpEF‐HEAT (−0.61 ± 0.25; P > 0.05). During contractions, the noradrenergic response was not different between HFpEF‐CON and HFpEF‐HEAT (−0.94 ± 0.07 and −0.86 ± 0.09, respectively; P > 0.05). Moreover, the magnitude of sympatholysis was lower in both HFpEF‐CON and HFpEF‐HEAT compared to healthy. Taken together, these results indicate that heat therapy failed to improve functional sympatholysis in HFpEF rats but restored the noradrenergic response in resting skeletal muscle.
1 October 2024 in Medicine & Science in Sports & Exercise
Post-activation performance enhancement (PAPE) strategies are used to improve power-dependent performance, but their impact on endurance exercise and skeletal muscle oxygenation is less clear. We tested the hypothesis that acute hex-bar deadlift (HBD) exercise would improve cycling performance and vastus lateralis muscle oxygen saturation (SmO2). Twenty-five healthy young adults (15 men, 10 women) completed moderate- and severe-intensity cycling after HBD or dynamic stretching (DYN) in a randomized crossover design. HBD consisted of 3 × 5 repetitions at 70–80% of one-repetition maximum, followed by ~8 min of recovery before cycling. Severe-intensity time-to-exhaustion was the primary outcome, while heart rate, arterial blood pressure, pulmonary oxygen uptake (V̇O2), and SmO2 were assessed as secondary physiological outcomes. Time-to-exhaustion was not different between HBD and DYN (394 ± 36 vs. 381 ± 34 s; p = 0.692). Resting and end-contraction V̇O2 and SmO2 were not different between conditions during moderate- or severe-intensity cycling. Similarly, SmO2 kinetics and area under the SmO2 curve remained unchanged. No condition-related differences in V̇O2 kinetics remained significant after correction for multiple comparisons. Contrary to our hypothesis, acute HBD exercise did not enhance vastus lateralis muscle oxygenation or severe-intensity cycling tolerance in healthy adults.
The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O 2 delivery‐utilization matching. The two main isoforms, COX‐1 and COX‐2, may promote opposing effects on contracting muscle O 2 transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX‐2 and its main vasodilatory product (prostacyclin, PGI 2 ) modulate microvascular O 2 transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX‐2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double‐blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake (), leg muscle microvascular oxygenation (; near‐infrared spectroscopy) and time to exhaustion. Leg muscle was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI 2 metabolite 6‐keto prostaglandin F 1α (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary or leg muscle from rest to moderate or severe exercise between conditions ( P > 0.05 for all). Moreover, there was no significant difference in during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX‐2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.